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Abstract
The aim of this paper is to consider how changes in service planning and de-
livery might improve the care pathways for adult anorexia nervosa. Although
anorexia nervosa has a long history in Europe, its framing as a mental disorder
is quite recent. The changing forms and increasing epidemiology of eating
disorders has led to the expansion of specialised services. Although some ser-
vices provide care over the entire clinical course, more often services are
divided into those that care for children and adolescents or adults. The tran-
sition needs to be carefully managed as currently these services may have a
different ethos and expectations. Services for adults have a broad range of di-
versity (diagnostic subtype, medical severity, comorbidity, stage of illness and
psychosocial functioning) all of which impacts on prognosis. A tailored,
approach to treatment planning could optimise the pathway. Facilitating early
help seeking and rapid diagnosis in primary care and reducing specialised
services waiting lists for assessment and treatment could be a form of secondary
prevention. The use of precision models and /or continuous outcome moni-
toring might reduce the third of patients who require more intensive care by
applying augmentation strategies. Finally, gains from intensive care might be
sustained by relapse prevention interventions and community support to bridge
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the transition home. Together these measures might reduce the proportion of
patients (currently a third) with ill health for over 20 years. For this group
rehabilitation strategies may improve functioning until new treatment emerge.
K E Y W O R D S
anorexia nervosa, care pathways, cost effectiveness, eating disorders, service planning
1 | INTRODUCTION
In this paper, we consider care pathways for adult
anorexia nervosa from the European perspective in order
to provide the context for a European project on
improving the value of treatment. We use information
from UK, Spain and Germany as case studies.
2 | THE HISTORICAL DEVELOPMENT
OF SERVICES
The historical precedent for the treatment of adult
anorexia nervosa was admission for refeeding to an in-
ternal medical setting, in England (Gull, 1874), as also
Spain and Germany (Partagaz, 1903; Saltro‐Lavall, 1883).
This form of care continued until the 1970s. During the
latter part of the 20th century, an increase in the preva-
lence and incidence of ED in Europe has been observed
(Galmiche, Déchelotte, Lambert, & Tavolacci, 2019;
Specialised inpatient units and community teams were
developed within psychiatric or psychosomatic (in Ger-
many) settings. In the UK, approximately 50 % of the
inpatient units were developed by private health care
providers (although these were commissioned and paid
for by the NHS as were the outpatient services). Most of
the Spanish units were publically funded by a universal
care system. In Germany, all patients with an eating
disorder are covered by private or statutory health in-
surance adult patients and in and outpatients are treated
in Departments for Psychosomatic Medicine and Psy-
chotherapy (Zipfel, Herzog, Kruse, & Henningsen, 2016).
Specialised therapy centres for patients with eating dis-
orders that can treat the entire age range and all di-
agnoses of eating disorders are still the exception in
Germany, Spain and the UK. This gradual evolution has
led to a wide diversity in the type of service available. In
Germany, for example, special counselling centres are
available for mild/early cases and in the UK, the
Improving Access to Psychological Therapies programme
service in some areas is used for less severe cases. Across
Europe, alternative forms of specialised intensive care
have been introduced (home treatments, day and
residential care, specialised group therapies for ED sub-
types/gender, etc.; Agüera et al., 2015, 2017; Anastasia-
dou et al., 2020; Serrano‐Troncoso et al., 2020; Herpertz‐
Dahlmann, van Elburg, Castro‐Fornieles, &
Schmidt, 2015).
In the UK, many of the first specialist units were
developed in academic settings. In Germany, a centre at
the University Hospital of Tübingen (KOMET) in which
several university disciplines (including Psychiatry,
Endocrinology and Gynaecology, and others) co develop
and evaluate innovative treatments under the direction of
the Department of Psychosomatic Medicine and Child
and Adolescent Psychiatry. In Spain, multidisciplinary
teams and research networks were developed in order to
improve translational research around ED and obesity
(CIBERobn; https://www.ciberobn.es).
Highlights
When considering the care pathway for adults
with anorexia nervosa there are several pinch
points which if remediated may improve patient
flow and outcomes.
� First, improving awareness and recognition in
primary care to facilitate early engagement in
treatment.
� Second, reduce the time to access specialist
treatment.
� Third, increasing the effectiveness of routine
treatment (outpatient) possibly through a
triage system with a precision planning and
continuous monitoring with the provision of
augmentation strategies.
� Fourth, the impact of inpatient care can be
optimised by interventions that bridge the
transition home and increase community
support.
� Finally, a rehabilitation approach and new
treatment strategies for those who do not
respond to standard treatment.
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3 | STAKEHOLDER APPRAISAL OF
EATING DISORDER SERVICES
Consumer concerns about services within Spain and the
UK has led to a move to review and revise service
structures and workforce training (Ombudsman, 2017, p.
2; Yárnoz‐Esquíroz, Lacasa, Riestra, C., & Früh-
beck, 2019). Surveys of patients, carers and other stake-
holders have established the key ingredients of a high‐
quality ED service, namely well‐coordinated care deliv-
ered by a knowledgeable and specialist treatment team
centred around the patient and their social support
(Escobar‐Koch, et al., 2010; van Furth, van der Meer, &
Cowan, 2016; Hart & Wade, 2019; Nishizono‐Maher,
Escobar‐Koch, & Ringwood, 2010). A recent systematic
review proposed three main themes (better use of pri-
mary care to engage patients; the involvement of a range
of services from primary care through to acute medical
services with mutual collaboration between pro-
fessionals, patients and families (Johns, Taylor, John, &
Tan, 2019). Also given the evolving knowledge base, it is
important that services should be able to appraise, inte-
grate and implement new evidence into their clinical
practice. Central EU policies with funding and training to
reach these standards have been developed or being
developed.
4 | POLICY AND SERVICES
As a case example, some of the UK policy documents that
underpin changes in services and workforce training are
shown in Table 1. These changes in the UK and Spain
include better integration with primary and acute care
services and less use of out of area inpatient bed.
5 | THE CARE PATHWAYS
Primary care in the UK, Spain and Germany, general
practitioners are the primary gatekeeper to access
specialist services. However, a characteristic feature of
anorexia nervosa is that individuals do not consider
themselves to have an illness. Therefore, as young adults
they may not seek, and/or avoid and delay treatment for
some time. The process of help seeking and referral to
services can take between 2 and 5 years in adult services
(Austin, et al., 2020). However, it is worth noting that for
2 years before the diagnosis was established in Welsh
primary care settings, there had been an increase in visits
associated with prescriptions for psychological or
gastrointestinal complaints suggesting diagnostic delay is
also of relevance (Demmler, Brophy, Marchant, John, &
Tan, 2020). Moreover the incidence of anorexia nervosa
detected in primary care in the UK and Spain has
remained constant over the last 3 decades (Aguilar
Hurtado et al., 2004; Micali, Hagberg, Petersen, & Trea-
sure, 2013) whereas other sources of ascertainment sug-
gest that there may have been an increase in numbers
(Galmiche et al., 2019). In Germany, the average increase
in diagnoses for one large insurer between 2011 and 2016
was 7.5% (https://www.aerzteblatt.de/nachrichten/
94751/Essstoerungen-auf-dem-Vormarsch). Late detec-
tion and treatment delays are associated with poorer
prognosis (Andres‐Perpiña et al., 2020; Fernández‐Ara-
nda et al., 2020) and increased burden (Yárnoz‐Esquíroz
et al., 2019) and therefore improving awareness and early
diagnosis and access to treatment may reduce the in-
crease in severity illness which has been manifest in the
UK in terms of increased bed use (Holland, Hall, Yeates,
& Goldacre, 2016).
However in Germany, a public health intervention
aimed at shortening the delay (36.5 months (SD = 68.2)
in accessing treatment failed to find any impact (Gumz,
Weigel, Wegscheider, Romer, & Löwe, 2018). On the
other hand, the preliminary findings from a digital
intervention (Pro youth) designed to reduce delays in
help seeking found that approximately 17 % were moti-
vated to seek help following the intervention (Moessner,
Minarik, Özer, & Bauer, 2016). Stigma and low mental
health literacy were noted as barriers to help seeking.
In the UK depending on how services are, commis-
sioned GPs may refer onto a generic psychiatric or psy-
chological therapy service or directly to a specialist
service (Currin, Schmidt, Yeomans, & Waller, 2006). The
pattern may in part be driven by the local availability of
specialist services. Augmentation strategies given pre
(Muir, et al., 2017) or postspecialist assessment (Cardi
et al., 2020) have so far only shown limited benefit
although a service which fast tracked those with a short
duration of illness improved outcomes (flynn et al 2021).
6 | SPECIALIST ASSESSMENT
There is a wide diversity between presentations of
anorexia nervosa to adult services. These include dura-
tion of illness, severity, level of risk, diagnostic subtype
(restricting vs. binge purge), medical (e.g., diabetes) and
psychological comorbidity (such as ASD, ADHD, obses-
sive compulsive disorder, depression, borderline person-
ality, substance use disorders) and psychosocial
functioning. The biopsychosocial aspects that may
maintain the illness include isolation, stress, and aspects
of neuroprogression treasure willmott 2020). Ideally these
should be considered in the assessment so that the
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treatment can be personalised with a precision approach
(Kan, Cardi, Stahl, & Treasure, 2019; Kan &
Treasure, 2019).
The baseline profile of cases enrolled into a recent
multicentre study (in the UK from adult eating disorder
community services found that 13% had severe weight
loss (BMI < 15), 67% with moderate weight loss (BMI 15–
17) and 20% with mild weight loss (BMI 17–18.5; Cardi
et al., 2020). In terms of illness duration, 30% had less
than 3 years of illness, 50 % had an established illness (3–
7 years) and 20% had an illness that had persisted for over
7 years (Cardi et al., 2020).
The baseline data from one of the biggest adults ED
Units in Spain is similar. We found that 15.7% had severe
weight loss (BMI < 15), 38.9% with moderate weight loss
(BMI 15–17) and 42.6% with mild weight loss (BMI 17–
18.5). In Spain, following the COVID pandemic, more
severe weight loss and higher symptomatology has been
observed in several Spanish services (Baenas et al., 2020;
Fernández‐Aranda et al., 2020; Graell et al., 2020).
7 | PROGNOSTIC OR STAGING
MARKERS OF ANOREXIA NERVOSA
The form and severity of the illness may lead to a plan to
deliver treatment in the community or in a more inten-
sive specialist setting (day or inpatient care).
Delay in access to specialised care, longer duration of
the ED, a lower BMI, higher comorbidity, associated
personality traits and lower motivation at discharge have
been found to be associated with poorer prognosis in
several Spanish studies (Andres‐Perpiña, 2020; Beato‐
Fernandez et al., 2020; Castro‐Fornieles et al., 2007;
Fernández‐Aranda et al., 2020; Riesco et al., 2018). These
align with the findings from an earlier systematic review
(Vall & Wade, 2016).
There has been interest in the possibility of using a
precision psychiatry strategy for staging the illness. Proxy
markers such as duration and severity have been
considered and the term severe and enduring stage of
illness has been used. However, this simplified model is
controversial, and the parameters are uncertain
(Broomfield, Stedal, Touyz, & Rhodes, 2017; Fernández‐
Aranda et al., 2020; Treasure & Schmidt, 2013; Wonder-
lich, Bulik, Schmidt, Steiger, & Hoek, 2020).
BMI has been used by the DSM 5 as a marker of
severity (APA, 2013). It is a surrogate marker of medical
risk approximating to the need to access more intensive
forms of treatment but there is uncertainty about its role
as a prognostic or stage marker. Duration also has not
always been found to be associated with a negative
prognosis (Fernández‐Aranda et al., 2020; Radunz,
Keegan, Osenk, & Wade, 2020). However, in SHARED
(multicentre OPD trial in UK) depression in combination
with duration was associated with a worse outcome
whereas duration alone did not (Ambwani et al., 2020).
Thus, more complex models for staging and precision
psychiatry using data from many variables, larger studies
and machine learning may be needed.
Weight gain during the early phase of treatment is
also a prognostic marker (Nazar et al., 2017; Vall &
Wade, 2016) especially if this is combined with a BMI
above 17 at baseline. This suggests that early monitoring
T A B L E 1 Policy documents
relating to eating disorder services in
the UK
Table recent policy documents for eating disorder service in UK
2017 Ignoring the alarms: How NHS eating disorder services are failing patients (2017)
Parliamentary and Health Service ombudsman.
2018 Welsh Government. Eating disorder service review
2019 Adult eating disorders: community, inpatient and intensive day patient care.
Guidance for commissioners and providersPublishing approval number:
000957. Version number: 1First published: August 2019. Prepared by NHS
England with NICE and the National Collaborating centre for mental health
2020 QED quality standards for adult community eating disorder services. Second
Edition. Publication number: CCQI344. Royal College of Psychiatrists. Editor:
Hannah Lucas
2020 Health Education England: Cognitive behavioural therapy for severe mental health
problems eating disorder pathway and adult eating disorders wholeTeam
training Specification Published:2020Prepared by: Health Education England
2020 Community mental health planning. TransformationNHS England health
improvement
2020 Community eating disorder programme (Pan London & others)Mental health
Transformation Board. NHS England
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of the progression of therapy and augmenting care for
those with a suboptimal response may be of benefit
rather than basing treatment decisions on parameters
measured at baseline.
8 | MATCHING PATIENTS TO
SERVICES WITHIN THE CARE
PATHWAY
As seen from the discussion above matching patients to
the form of service within the care pathways is an
imprecise art. There are many factors that impact on how
service users respond to treatment and flow through the
system. A recent development in the UK has been the
introduction of early intervention services for people with
a duration of anorexia nervosa of less than 3 years
(FREED) to reduce delays post‐help seeking. These have
been found to improve retention and outcomes. For
example, weight recovery at 12 months in the FREED
group was 56%–59% in comparison to the treatment as
usual group (19%–30%) and the need for intensive (in/day
patient) treatment 6.6%–8.9% compared with treatment
as usual 12.4%–14.1% (Fukutomi, Austin, & McClel-
land, 2020; McClelland, Kekic, Bozhilova, Nestler, &
Dew, 2016). However, there is less certainty about the
group with a longer illness, which may have not
responded to earlier treatment.
9 | SPECIALISED OUTPATIENT
TREATMENTS
A variety of specialist outpatient treatments have been
developed for the management of adult outpatients with
anorexia nervosa, but most are time limited interventions
(20–60 sessions usually spanning less than a year). Most
of these have some degree of multidisciplinary integra-
tion with sessions for families/carers or for nutritional
advice.
Systematic reviews synthesising the evidence have
failed to find differences between models of treatment in
terms of clinical outcomes, which are on the whole
disappointing with high dropout rates (Riesco et al., 2018;
Van den Berg, Houtzager, & de Vos, 2019). Only a third of
cases were classified as recovered at 2 years (Murray,
Quintana, Loeb, Griffiths, & Le Grange, 2019; Zeeck
et al., 2018). The proportion of outpatients switched to
inpatient “rescue” treatment ranges from 8% to 41.0%
with variation between studies and between treatments.
The highest levels (41%) of rescue treatment reported
were in the optimised treatment as usual arm from a high
quality randomised control trial conducted in Germany
(Zipfel, Wild, & Groß, 2014). The lower need for rescue
treatment in both the cognitive behavioural treatment
arm and the focal psychodynamic therapy arm contrib-
uted to the higher cost‐effectiveness of the latter form of
treatment (Egger et al., 2016).
A similar pattern of lower admissions (by over 50%)
was found with specialist interventions (MANTRA and
SSCM) in the MOSAIC RCT study (n = 142; MANTRA
and SSCM; Schmidt, Magill, & Renwick, 2015) when
compared with treatment as usual from UK clinics in the
SHARED (n = 187) multicentre study (Cardi et al., 2020;
Figure 1). The level of rescue treatment is thus of rele-
vance for service planning however this is not often
explicitly reported in trials and the clinical decision‐
making underpinning it may vary.
The presence of bingeing/purging behaviours and
longer duration of illness were associated with higher
outpatient costs in the German ANTOP study, as was the
presence of additional mental health problems (Stuhl-
dreher et al., 2015).
10 | THE MANAGEMENT OF HIGH‐
RISK ANOREXIA NERVOSA: INPATIENT
AND DAY PATIENT CARE
More intensive services (day care and inpatient settings)
are used to manage risk (medical and psychological). In
the UK, the admission BMI for inpatient care in a mul-
ticentre study was approximately 15 kg/m2 (Hibbs
et al., 2015) Nutritional restoration is the main target to
manage risk. The average weekly inpatient weight gain
for adults was 0.537 kg compared to weight gain of 0.1
week in outpatients; Zeeck, et al., 2018). However, there
is very little empirical evidence to guide the parameters of
inpatient care (see systematic review of length of stay
Cribben kan treasure european eating review 2020 this is
in this addition I cannot find it though which shows
cultural differences. For example, admissions in Europe
were longer than for other countries. LOS, in turn, is
impacted by weight on admission (lower in Europe). A
German study found that a lower BMI at admission, a
purging AN‐subtype as well as higher EDI‐2 asceticism
were associated with longer admissions (Kästner,
et al., 2018).
Transition into and out of inpatient, care can be
challenging. Relapse after discharge lies between 20% and
50% (Hibbs, et al., 2015). A variety of strategies to reduce
relapse have been tested in feasibility studies (transition
systematic review).
Guided self‐help approaches linking with community
support using a variety of digital approaches hold
promise. Several large, randomised trials which provide
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augmented psychological support for patients and fam-
ilies (TRIANGLE; Cardi et al., 2017) and SUSTSAIN are
in progress.
11 | DAY PATIENT AND HOME
TREATMENT
Less intensive treatment such as day care is more variable
in terms of number and length of each day and hence the
number of supported meals and the admission BMI is
usually higher than that of patients for inpatient stay.
In a Spanish study, an average baseline BMI was 16.7
in ANR and of 17.2 in ANBP (Agüera, et al., 2015) Full‐
partial or remission of symptoms was found in 55.7% and
70.9%, in AN‐R and ANBP in the short term. The likeli-
hood of partial or full remission was higher for patients
who were older and had high baseline BMI.
A variety of alternative forms of specialised intensive
care have been introduced (home treatments, day and
residential care, specialised group therapies for ED sub-
types/gender, etc.; Agüera et al., 2017; Anastasiadou
et al., 2020; Peckmezian & Paxton, 2020; Reilly, Rockwell,
& Ramirez, 2020; Serrano‐Troncoso et al., 2020).
12 | NEW TREATMENTS
Services for eating disorders were early adopters of
guided self‐management approaches and were poised to
innovate and reset services in the post COVID world. The
specialised skills that can support people with anorexia
nervosa have been manualised and digitised and can be
delivered with online support of various forms (group/
individual/family). The concerns that this form of man-
agement might be problematic given the risk and
ambivalence about treatment (Wilson & Zandberg, 2012)
does not seem to be a barrier. Indeed dropout is lower in
this form of management (Albano, Hodsoll, Kan, Lo
Coco, & Cardi, 2019).
Of course, there needs to be a secure system to mea-
sure medical risk possibly recruiting help from the family
or primary care. Thus digital systems are of promise in a
variety of forms to augment treatment such as virtual
reality to target food or body image fears and training
approaches to improve food and social approach behav-
iours. Also given the long course of the illness, a recovery
approach with peer support may enhance hope (Ran-
zenhofer et al., 2020). Social support provided from
family, friends and people with lived experience in
connection with a consultative and tailored service
approach might allow a more optimised, personalised
approach to care (Treasure, Willmott, et al., 2020).
Work is in progress developing new forms of treat-
ment for the group of patients who are resistant to
standard treatment. Thus, neuromodulation using either
deep brain stimulation (Lipsman et al., 2017; Villalba
Martinez et al., 2020) or repetitive transcranial magnetic
stimulation may have a role (Dalton et al., 2020).
13 | CONCLUSION
High‐quality services for adult eating disorders involve an
admixture of community‐focused care supported with a
step up to higher intensity day and/or inpatient provision
F I G U R E 1 Outcomes (a) change in BMI (b) percentage transferred into a higher level of care “rescue treatment” from two UK
multicentre randomised trials. MANTRA Maudsley model of anorexia nervosa treatment for adults. SSCM (specialised supportive clinical
management; Schmidt et al., 2015) and SHARED self‐help and recovery guide for eating disorders (Cardi et al., 2020) in which TAU
treatment as usual (informed by the NICE guidelines) was delivered
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as needed. Specialist interventions should be delivered in
a timely manner. Reducing treatment delays for those in
the early stage of illness (defined as either duration or
severity of weight loss) can improve outcome and reduce
the need for more intense levels of care.
Nevertheless, the outcomes of treatment for adult
anorexia nervosa are disappointing. Therefore, various
strategies to augment care are being tested. Specialised
structured treatments produce better outcomes than
treatment at usual in terms of the need for rescue beds.
Intensive treatments (in and day patient care) remediate
symptoms but relapse post discharge is common. Psy-
chological interventions to bridge the transfer to home
hold promise as a means of sustaining the benefit from
inpatient care. The expertise from a multidisciplinary
team is needed for the functional remediation needed in
later stages of illness.
The pathways into and through these services need to
be carefully delineated and yet be personalised and flex-
ible. There are several pinch points that may warrant
further attention. These include reducing delays in help
seeking and accessing specialised care. A precision
approach matching care to the profile of the patient with
continuous monitoring of the response to treatment and
augmenting care as needed is warranted. For those who
require intensive care the transition home needs to be
carefully managed. Community support is of benefit to
sustain the gains made during treatment and the role of
peers and wider support systems is under review.
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